Seadrill Ltd. SDRL 深 沪
等待开盘 08-01 09:30:00 美东时间
29.08
-0.690
-2.32%
华盛通- 最 高30.00
- 今 开29.39
- 成交量 47.83万股
- 最 低 28.87
- 昨 收 29.77
- 总市值 18.10亿
- 52周最高 45.82
- 市盈率 静 4.63
- 换手率 0.77%
- 52周最低 17.74
- 委 比 -96.32%
- 总股本 6222.53万
- 历史最高 56.46
- 量 比 0.79
- 振 幅 3.80%
- 历史最低 0.10
- 每 手 1
- 风险率 8.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅261.01%！瑞穗上调Immuneering目标价至10美元，维持"跑赢大市"评级
康托·菲茨杰拉德：维持Meta Platforms(META)"超配"评级，目标价从676美元升至807美元
06-19 09:23
Citigroup Maintains Buy on Seadrill, Raises Price Target to $36
Citigroup analyst Scott Gruber maintains Seadrill (NYSE:SDRL) with a Buy and raises the price target from $35 to $36.
06-18 21:39
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
BWS Financial Maintains Buy on Seadrill, Maintains $80 Price Target
BWS Financial analyst Hamed Khorsand maintains Seadrill (NYSE:SDRL) with a Buy and maintains $80 price target.
05-13 21:23
Seadrill shares are trading lower following a Q1 EPS miss.
Seadrill shares are trading lower following a Q1 EPS miss.
05-12 21:17
Seadrill reports mixed Q1 results; reaffirms FY25 outlook
Seadrill press release (NYSE:SDRL): Q1 GAAP EPS of -$0.23 misses by $0.57. Revenue of $335M (-8.7% Y/Y) beats by $5.38M. Adjusted EBITDA was $73 million, compared to $28 million in the prior quarter. ...
05-12 18:12
Earnings Scheduled For May 12, 2025
Companies Reporting Before The Bell • Superior Industries Intl (NYSE:SUP) is pr...
05-12 16:32
Top 3 Energy Stocks You'll Regret Missing In Q2
The most oversold stocks in the energy sector presents an opportunity to buy in...
04-08 19:46
美股大行评级 | Compass Point：上调Affirm Holdings评级至"买入"，目标价从61美元升至64美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1109399410911752193.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Femasys Inc Ordinary Shares(FEMY)"买入"评级，目标价从12美元升至15美元</p> <p>• HC Wainwright & C
03-20 09:49
